Previous close | 15.23 |
Open | 15.66 |
Bid | 14.65 x 100 |
Ask | 14.94 x 100 |
Day's range | 14.71 - 15.66 |
52-week range | 3.15 - 30.40 |
Volume | |
Avg. volume | 74,077 |
Market cap | 1.267B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Gyre Therapeutics ( NASDAQ:GYRE ) First Quarter 2024 Results Key Financial Results Revenue: US$27.2m (down 1.6% from 1Q...
Key Insights Significant control over Gyre Therapeutics by public companies implies that the general public has more...
Transformational Year with Strategic Shifts and Clinical Advances